ECONOMIC EVALUATION OF PANITUMUMAB AND CETUXIMAB IN THE TREATMENT OF PATIENTS WITH EGFR EXPRESSING MCRC WITH NON-MUTATED (WILD-TYPE) KRAS IN GREECE: A COST MINIMIZATION ANALYSISVALUE IN HEALTHIF62011-11-010OAAI
A COST-EFFECTIVENESS ANALYSIS OF DENOSUMAB FOR THE TREATMENT OF POST-MENOPAUSAL OSTEOPOROSIS IN GREECEVALUE IN HEALTHIF62011-11-013OAAI
THE ECONOMIC BURDEN OF POST-MENOPAUSAL OSTEOPOROSIS AND RELATED FRACTURES IN GREECEVALUE IN HEALTHIF62011-11-011OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向